News

Article

Psychedelics Beyond Clinical Settings Poll

Author(s):

Psychiatric Times Editors

Answer a quick question on psychedelics!

Have your patients shared or expressed interest in psychedelics for therapeutic purposes outside of clinical settings?

Yes, patient(s) have shared their interest
No, patient(s) have not talked about it
Related Videos
Tasphong/AdobeStock
Andrii Yalaanskyi/AdobeStock
Jorm Sangsorn/AdobeStock
RolfImages/AdobeStock
CravenA/AdobeStock
brain
Related Content
brain scan
May 12th 2025

What’s Perfusion Got to Do With It?

Steven R. Devore Best, MD Dan Pavel, MD
Here's to a Psychedelic Revolution
April 9th 2022

Here's to a Psychedelic Revolution

Amir Inamdar MBBS, DNB (Psych), MFPM
COVID
March 11th 2025

Psilocybin Benefits Clinicians Traumatized on Front Line of COVID-19 Pandemic

Kenneth J. Bender, PharmD, MA
David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders
April 6th 2021

David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders

Angela A. Coombs, MD Jennifer Sotsky, MD, MS
Ronstik/AdobeStock
February 14th 2025

Week in Review: February 10-14

Megan McSweeney
psychedelic
February 10th 2025

CYB003 for the Adjunctive Treatment of Major Depressive Disorder

Leah Kuntz
© 2025 MJH Life Sciences

All rights reserved.